FDA Inspection 1146849 — Michael J. Downing, M.D.
The FDA completed an inspection of Michael J. Downing, M.D. on Jul 15, 2021 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 15, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dallas, TX (United States)
Additional details
Clinical Investigator (CI)